{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:37Z","timestamp":1790785177014,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jpsychires.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T23:35:45Z","timestamp":1675812945000},"page":"137-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9267-6283","authenticated-orcid":false,"given":"Hiba","family":"Mutwalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna Louise","family":"Keeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Bektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Dhopatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hup.2278","article-title":"Olanzapine and food craving: a case control study","volume":"28","author":"Abbas","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0019-5545.31618","article-title":"A preliminary open trial of olanzapine in paediatric acute and transient psychotic disorders","volume":"48","author":"Agarwal","year":"2006","journal-title":"Indian J. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.02.006_bib3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1111\/obr.12934","article-title":"Effects of antidepressant and antipsychotic use on weight gain: a systematic review","volume":"20","author":"Alonso-Pedrero","year":"2019","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1089\/cap.2005.15.869","article-title":"Acute and long-term safety and tolerability of risperidone in children with autism","volume":"15","author":"Aman","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/cap.2015.0005","article-title":"Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial","volume":"25","author":"Aman","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1024\/1422-4917\/a000165","article-title":"Subjective and biological weight-related parameters in adolescents and young adults with schizophrenia spectrum disorder under clozapine or olanzapine treatment","volume":"40","author":"Bachmann","year":"2012","journal-title":"Z. Kinder JugenPsychiatr. Psychother."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/0269881118754708","article-title":"Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo","volume":"32","author":"Ballon","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis","volume":"19","author":"Barton","year":"2020","journal-title":"Expet Opin. Drug Saf."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5455\/bcp.20121203034039","article-title":"Aripiprazole use in children and adolescents: a public hospital child psychiatry outpatient department's experience","volume":"24","author":"Basgul","year":"2014","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bulletin of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.encep.2008.03.009","article-title":"[Assessing various aspects of the motivation to eat that can affect food intake and body weight control]","volume":"35","author":"Bellisle","year":"2009","journal-title":"Encephale"},{"issue":"7","key":"10.1016\/j.jpsychires.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/15622975.2010.505663","article-title":"Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study","volume":"11","author":"Bitter","year":"2010","journal-title":"World J. Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1176\/appi.ajp.2014.13101348","article-title":"Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial","volume":"171","author":"Black","year":"2014","journal-title":"Am. J. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/oby.2008.277","article-title":"Adiposity and eating behaviors in patients under second generation antipsychotics","volume":"16","author":"Blouin","year":"2008","journal-title":"Obesity"},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/obr.12257","article-title":"Appetite control and energy balance: impact of exercise","volume":"16","author":"Blundell","year":"2015","journal-title":"Obes. Rev."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/104012371102300306","article-title":"Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression","volume":"23","author":"Bobo","year":"2011","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/136158","article-title":"Adverse effects of risperidone in children with autism spectrum disorders in a naturalistic clinical setting at siriraj hospital, Thailand","volume":"2014","author":"Boon-Yasidhi","year":"2014","journal-title":"Psychiatry J"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1753-2000-6-21","article-title":"Correlates of weight gain during long-term risperidone treatment in children and adolescents","volume":"6","author":"Calarge","year":"2012","journal-title":"Child Adolesc. Psychiatr. Ment. Health"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cap.2012.0046","article-title":"Iron deficiency in pediatric patients in long-term risperidone treatment","volume":"23","author":"Calarge","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113168","article-title":"Safety of antipsychotic drugs: a systematic review of disproportionality analysis studies","volume":"404","author":"Cepaityte","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.orcp.2020.12.005","article-title":"Metformin-induced weight loss in patients with or without type 2 diabetes\/prediabetes: a retrospective cohort study","volume":"15","author":"Chukir","year":"2021","journal-title":"Obes. Res. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00152","article-title":"Safety and tolerability of antipsychotic drugs in pediatric patients: data from a 1-year naturalistic study","volume":"11","author":"Cicala","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib22","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"2013"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10597-019-00462-0","article-title":"Associations between two domains of social adversity and recovery among persons with serious mental illnesses being treated in community mental health centers","volume":"56","author":"Compton","year":"2020","journal-title":"Community Ment. Health J."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib24","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.MY20096AH1C","article-title":"Treatment-resistant schizophrenia: definition, predictors, and therapy options","volume":"82","author":"Correll","year":"2021","journal-title":"J. Clin. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5350\/KPB-BCP201121106","article-title":"Risperidone treatment in preschool children with disruptive behavior disorders: a chart review study","volume":"21","author":"Coskun","year":"2011","journal-title":"Klinik Psikofarmakoloji B\u00fclteni-Bulletin of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00004714-200108000-00004","article-title":"Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America","volume":"21","author":"Costa e Silva","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/YIC.0000000000000052","article-title":"Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men","volume":"30","author":"Daurignac","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"10278","key":"10.1016\/j.jpsychires.2023.02.006_bib28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2020.07.017","article-title":"The insight paradox in schizophrenia: a meta-analysis of the relationship between clinical insight and quality of life","volume":"223","author":"Davis","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib30","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2147\/NDT.S113099","article-title":"Antipsychotic-associated weight gain: management strategies and impact on treatment adherence","volume":"13","author":"Dayabandara","year":"2017","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/JCP.0000000000001357","article-title":"Binge eating disorders in antipsychotic-treated patients with schizophrenia: prevalence, antipsychotic specificities, and changes over time","volume":"41","author":"de Beaurepaire","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib32","first-page":"919","article-title":"Clozapine, a novel major tranquilizer. Clinical experiences and pharmacotherapeutic hypotheses","volume":"22","author":"de Maio","year":"1972","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib33","first-page":"310","article-title":"Efficacy, tolerability, compliance, and quality of life of patients with mood disorders switched from quetiapine immediate release to extended release","volume":"27","author":"Dell'Osso","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.9758\/cpn.2017.15.4.328","article-title":"A retrospective study of long acting risperidone use to support treatment adherence in youth with conduct disorder","volume":"15","author":"Demirkaya","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ecl.2013.05.006","article-title":"Effects of antipsychotic medications on appetite, weight, and insulin resistance","volume":"42","author":"Deng","year":"2013","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr. Clin. Trials"},{"issue":"449","key":"10.1016\/j.jpsychires.2023.02.006_bib37","first-page":"89","article-title":"A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval","year":"2000","journal-title":"J. Am. Stat. Assoc."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.02.006_bib38","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaac.2015.09.007","article-title":"Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder","volume":"54","author":"Findling","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00004583-200302000-00010","article-title":"A prospective, open-label trial of olanzapine in adolescents with schizophrenia","volume":"42","author":"Findling","year":"2003","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/cap.2010.0102","article-title":"An open-label study of aripiprazole in children with a bipolar disorder","volume":"21","author":"Findling","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib41","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/oby.2010.6","article-title":"Increased food intake and energy expenditure following administration of olanzapine to healthy men","volume":"18","author":"Fountaine","year":"2010","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/104454604773840472","article-title":"Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications","volume":"14","author":"Gagliano","year":"2004","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.02.006_bib43","first-page":"939","article-title":"Differential diagnosis of emotional disorders that cause weight loss","volume":"129","author":"Garfinkel","year":"1983","journal-title":"Can. Med. Assoc. J."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.02.006_bib44","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s00213-019-05291-3","article-title":"Food craving and consumption evolution in patients starting treatment with clozapine","volume":"236","author":"Garriga","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib45","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00702-007-0663-2","article-title":"Clozapine\/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders","volume":"114","author":"Gebhardt","year":"2007","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0253-7176.127254","article-title":"Effects of risperidone on core symptoms of autistic disorder based on childhood autism rating scale: an open label study","volume":"36","author":"Ghaeli","year":"2014","journal-title":"Indian J. Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12991-016-0112-4","article-title":"Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial","volume":"15","author":"Ghanizadeh","year":"2016","journal-title":"Ann. Gen. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10578-013-0427-1","article-title":"Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial","volume":"45","author":"Ghanizadeh","year":"2014","journal-title":"Child Psychiatr. Hum. Dev."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajp.2017.02.022","article-title":"Exploration of food addiction in people living with schizophrenia","volume":"27","author":"Goluza","year":"2017","journal-title":"Asian J Psychiatr"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib50","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/appi.ajp.159.6.1055","article-title":"Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine","volume":"159","author":"Gothelf","year":"2002","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib51","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.ALC.0000125352.06688.F7","article-title":"A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder","volume":"28","author":"Guardia","year":"2004","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib52","doi-asserted-by":"crossref","first-page":"e2498","DOI":"10.1002\/brb3.2498","article-title":"Effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta-analysis","volume":"12","author":"Han","year":"2022","journal-title":"Brain Behav"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2018.1557346","article-title":"WFSBP guidelines on how to grade treatment evidence for clinical guideline development","volume":"20","author":"Hasan","year":"2019","journal-title":"World J. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10803-006-0078-1","article-title":"A crossover study of risperidone in children, adolescents and adults with mental retardation","volume":"36","author":"Hellings","year":"2006","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10401230600614538","article-title":"Dietary intake profile of patients with schizophrenia","volume":"18","author":"Henderson","year":"2006","journal-title":"Ann. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1871530315666150623092031","article-title":"Weight gain and metabolic changes during treatment with antipsychotics and antidepressants","volume":"15","author":"Himmerich","year":"2015","journal-title":"Endocr., Metab. Immune Disord.: Drug Targets"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib57","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pedneo.2013.05.009","article-title":"Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: a naturalistic study","volume":"55","author":"Ho","year":"2014","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.2018.167","article-title":"Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial","volume":"214","author":"Holt","year":"2019","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib59","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.gerinurse.2013.06.010","article-title":"Features of problematic eating behaviors among community-dwelling older adults with dementia: family caregivers' experience","volume":"34","author":"Hsiao","year":"2013","journal-title":"Geriatr. Nurs."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2011.12.015","article-title":"Switching to aripiprazole in subjects with pervasive developmental disorders showing tolerability issues with risperidone","volume":"37","author":"Ishitobi","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1517\/17460441.2015.1044966","article-title":"Latest approaches for the treatment of obesity","volume":"10","author":"Jackson","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib62","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2018.02.047","article-title":"Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - baseline and two-years findings from the CHANGE trial","volume":"199","author":"Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2018.03.016","article-title":"Dietary patterns and physical activity in people with schizophrenia and increased waist circumference","volume":"199","author":"Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2023.02.006_bib64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archpsyc.58.10.965","article-title":"Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison","volume":"58","author":"Kane","year":"2001","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2009.05.024","article-title":"A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: the PLATYPUS Study","volume":"113","author":"Karagianis","year":"2009","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200210000-00003","article-title":"Open-label study of olanzapine in children with pervasive developmental disorder","volume":"22","author":"Kemner","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jpsychires.2023.02.006_bib67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1089\/cap.2012.0058","article-title":"An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder","volume":"23","author":"Kent","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib68","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10803-012-1723-5","article-title":"Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study","volume":"43","author":"Kent","year":"2013","journal-title":"J. Autism Dev. Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib69","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1007\/BF03325121","article-title":"Hunger and negative alliesthesia to aspartame and sucrose in patients treated with antipsychotic drugs and controls","volume":"14","author":"Khazaal","year":"2009","journal-title":"Eat. Weight Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12991-020-00314-2","article-title":"Biopsychosocial factors associated with disordered eating behaviors in schizophrenia","volume":"19","author":"Khosravi","year":"2020","journal-title":"Ann. Gen. Psychiatr."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.02.006_bib71","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the Cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4088\/JCP.v62n0204","article-title":"Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia","volume":"62","author":"Kinon","year":"2001","journal-title":"J. Clin. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/01.jcp.0000161501.65890.22","article-title":"Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders","volume":"25","author":"Kinon","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/jcp.0b013e31815a8872","article-title":"Clozapine and olanzapine are associated with food craving and binge eating - results from a randomized double-blind study","volume":"27","author":"Kluge","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13256-018-1622-2","article-title":"Aripiprazole-induced sleep-related eating disorder: a case report","volume":"12","author":"Kobayashi","year":"2018","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib76","series-title":"Lectures on Clinical Psychiatry","author":"Kraepelin","year":"1904"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib77","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib78","first-page":"531","article-title":"Beitr\u00e4ge zum Verlauf des K\u00f6rpergewichtes bei Psychosen","volume":"59","author":"Kryspin-Exner","year":"1947","journal-title":"Wien Klin. Wochenschr."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/1028415X.2017.1392429","article-title":"Assessment of the relationship between food addiction and nutritional status in schizophrenic patients","volume":"22","author":"K\u00fc\u00e7\u00fckerd\u00f6nmez","year":"2019","journal-title":"Nutr. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib80","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1007\/BF03325293","article-title":"Binge eating and other eating behaviors among patients on treatment for psychoses in India","volume":"15","author":"Kurpad","year":"2010","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2018.02.035","article-title":"Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients","volume":"199","author":"Lappin","year":"2018","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.02.006_bib82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jamapsychiatry.2017.1220","article-title":"Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial","volume":"74","author":"Larsen","year":"2017","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113830","article-title":"Effect of liraglutide 3.0mg treatment on weight reduction in obese antipsychotic-treated patients","volume":"299","author":"Lee","year":"2021","journal-title":"Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib85","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/13668250601006924","article-title":"Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study","volume":"31","author":"Lindsay","year":"2006","journal-title":"J. Intellect. Dev. Disabil."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib86","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1530-0277.2011.01649.x","article-title":"A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients","volume":"36","author":"Litten","year":"2012","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib87","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1176\/appi.ajp.163.1.156","article-title":"Prevalence of the night eating syndrome in a psychiatric population","volume":"163","author":"Lundgren","year":"2006","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib88","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/cap.2009.0035","article-title":"Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study","volume":"19","author":"Lyon","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.02.006_bib89","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/npp.2010.21","article-title":"Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis","volume":"35","author":"Maayan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00004583-200202000-00007","article-title":"Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness","volume":"41","author":"Malone","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib91","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/0003-066X.62.3.220","article-title":"Medicare's search for effective obesity treatments: diets are not the answer","volume":"62","author":"Mann","year":"2007","journal-title":"Am. Psychol."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib92","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/cap.2013.0063","article-title":"Quetiapine monotherapy in adolescents with bipolar disorder comorbid with conduct disorder","volume":"23","author":"Masi","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.02.006_bib93","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/archgenpsychiatry.2012.934","article-title":"Neural correlates of weight gain with olanzapine","volume":"69","author":"Mathews","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib94","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.02.006_bib95","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamapsychiatry.2017.3016","article-title":"Genetic association of major depression with atypical features and obesity-related immunometabolic dysregulations","volume":"74","author":"Milaneschi","year":"2017","journal-title":"JAMA Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib96","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0269881116654776","article-title":"Neural changes induced by antipsychotic administration in adolescence: a review of studies in laboratory rodents","volume":"30","author":"Moe","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib97","series-title":"Systematic Reviews of Etiology and Risk","author":"Moola","year":"2020"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2050-2974-1-27","article-title":"Psychotropic drug prescribing in an Australian specialist child and adolescent eating disorder service: a retrospective study","volume":"1","author":"Moore","year":"2013","journal-title":"J Eat Disord"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib99","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-3565(25)10792-1","article-title":"The behavioral pharmacology of olanzapine, a novel \"atypical\" antipsychotic agent","volume":"262","author":"Moore","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112606","article-title":"Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication","volume":"281","author":"Morell","year":"2019","journal-title":"Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib101","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.psyneuen.2004.05.008","article-title":"Olanzapine increases plasma ghrelin level in patients with schizophrenia","volume":"30","author":"Murashita","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib102","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/08830738060210060801","article-title":"Risperidone in children with autism: randomized, placebo-controlled, double-blind study","volume":"21","author":"Nagaraj","year":"2006","journal-title":"J. Child Neurol."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib103","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jamaoncol.2020.1052","article-title":"Olanzapine for the treatment of advanced cancer-related chronic nausea and\/or vomiting: a randomized pilot trial","volume":"6","author":"Navari","year":"2020","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib104","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/JCP.0000000000000956","article-title":"Risperidone but not quetiapine treatment is associated with increased appetite but not satiety hormones in children during an oral glucose tolerance test: a pilot study","volume":"38","author":"Ngai","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib105","series-title":"Psychosis and Schizophrenia in Adults: Treatment and Management","year":"2014"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib106","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bcpt.12803","article-title":"Pharmacogenomics and efficacy of risperidone long-term treatment in Thai autistic children and adolescents","volume":"121","author":"Nuntamool","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib107","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/CMAR.S191330","article-title":"Low-dose of olanzapine has ameliorating effects on cancer-related anorexia","volume":"11","author":"Okamoto","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pnpbp.2006.09.001","article-title":"Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia","volume":"31","author":"Onor","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib109","series-title":"Rayyan---a Web and Mobile App for Systematic Reviews","author":"Ouzzani","year":"2016"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib110","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib111","doi-asserted-by":"crossref","DOI":"10.1186\/1744-9081-9-27","article-title":"Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study","volume":"9","author":"Park","year":"2013","journal-title":"Behav. Brain Funct."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib112","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/cap.2019.0164","article-title":"Psychopharmacology in the pediatric oncology and bone marrow transplant units: antipsychotic medications palliate symptoms in children with cancer","volume":"30","author":"Peled","year":"2020","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.jpsychires.2023.02.006_bib113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/0706743718779950","article-title":"Harms of antipsychotics in children and young adults: a systematic review update","volume":"63","author":"Pillay","year":"2018","journal-title":"Can. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0253-7176.92067","article-title":"Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD","volume":"33","author":"Piparva","year":"2011","journal-title":"Indian J. Psychol. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010076","article-title":"The relationship between food craving, appetite-related hormones and clinical parameters in bipolar disorder","volume":"13","author":"Platzer","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/nu13010076","article-title":"The relationship between food craving, appetite-related hormones and clinical parameters in bipolar disorder","volume":"13","author":"Platzer","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib117","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-007-0731-1","article-title":"Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study","volume":"192","author":"Poyurovsky","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib118","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1176\/appi.ajp.160.2.297","article-title":"Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: a double-blind, placebo-controlled study","volume":"160","author":"Poyurovsky","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib119","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1089\/cap.2012.0094","article-title":"Are non-serious adverse reactions to psychiatric drugs really non-serious?","volume":"23","author":"Pozzi","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/2045125315581996","article-title":"An evaluation of subjective experiences, effects and overall satisfaction with clozapine treatment in a UK forensic service","volume":"5","author":"Qurashi","year":"2015","journal-title":"THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib121","article-title":"A comparative study of risperidone and aripiprazole in attention deficit hyperactivity disorder in children under six years old: a randomized double-blind study","volume":"28","author":"Razjouyan","year":"2018","journal-title":"Iran. J. Pediatr. (Engl. Ed.)"},{"issue":"10","key":"10.1016\/j.jpsychires.2023.02.006_bib122","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00228-018-2498-1","article-title":"Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews","volume":"74","author":"Ribeiro","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib123","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.jcp.0000177549.36585.29","article-title":"A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors","volume":"25","author":"Roerig","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.02.006_bib124","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/11596300-000000000-00000","article-title":"Atypical antipsychotic-induced weight gain: insights into mechanisms of action","volume":"25","author":"Roerig","year":"2011","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40261-021-01000-1","article-title":"Second-generation antipsychotic drugs for patients with schizophrenia: systematic literature review and meta-analysis of metabolic and cardiovascular side effects","volume":"41","author":"Rognoni","year":"2021","journal-title":"Clin. Drug Invest."},{"issue":"14","key":"10.1016\/j.jpsychires.2023.02.006_bib126","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jpsychires.2023.02.006_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113820","article-title":"Disordered eating among people with schizophrenia spectrum disorders: a systematic review","volume":"13","author":"Sankaranarayanan","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaac.2016.02.016","article-title":"Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder","volume":"55","author":"Scahill","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"17","key":"10.1016\/j.jpsychires.2023.02.006_bib129","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6","article-title":"An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials","volume":"17","author":"Schmid","year":"1998","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib130","first-page":"27","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/YIC.0b013e32832b6bf6","article-title":"Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients","volume":"24","author":"Sentissi","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib132","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajp.2014.05.001","article-title":"Antipsychotic induced metabolic changes & treatment response: a prospective study","volume":"11","author":"Sharma","year":"2014","journal-title":"Asian J Psychiatr"},{"issue":"10321","key":"10.1016\/j.jpsychires.2023.02.006_bib133","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0140-6736(21)01640-8","article-title":"Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials","volume":"399","author":"Shi","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.02.006_bib134","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0004867418772351","article-title":"Augmentation strategies for clozapine refractory schizophrenia: a systematic review and meta-analysis","volume":"52","author":"Siskind","year":"2018","journal-title":"Aust. N. Z. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.02.006_bib135","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.psychres.2012.03.011","article-title":"Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients","volume":"199","author":"Smith","year":"2012","journal-title":"Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.02.006_bib136","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2023.02.006_bib137","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jpsychires.2012.04.004","article-title":"Pilot study of the efficacy of double-blind, placebo-controlled one-week olanzapine stabilization therapy in heterogeneous symptomatic bipolar disorder patients","volume":"46","author":"Srivastava","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib138","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1038\/tp.2012.53","article-title":"Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment","volume":"2","author":"Stip","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/070674371205700104","article-title":"An overview of treatments for obesity in a population with mental illness","volume":"57","author":"Taylor","year":"2012","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2023.02.006_bib140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fpsyt.2018.00725","article-title":"Is obesity in young people with psychosis a foregone conclusion? Markedly excessive energy intake is evident soon after antipsychotic initiation","volume":"9","author":"Teasdale","year":"2018","journal-title":"Front. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib141","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0000000000000393","article-title":"Metabolic impairments precede changes in hunger and food intake following short-term administration of second-generation antipsychotics","volume":"35","author":"Teff","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.02.006_bib142","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib143","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00702-002-0792-6","article-title":"Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine","volume":"110","author":"Theisen","year":"2003","journal-title":"J. Neural. Transm."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib144","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.02.006_bib145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib146","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.154.4.457","article-title":"Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial","volume":"154","author":"Tollefson","year":"1997","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.02.006_bib147","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/15622970903079507","article-title":"Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: results from a six-month prospective, multinational, observational study","volume":"10","author":"Treuer","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.02.006_bib148","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.chi.0000177055.11229.76","article-title":"Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study","volume":"44","author":"Troost","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"14","key":"10.1016\/j.jpsychires.2023.02.006_bib149","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2023.02.006_bib150","article-title":"Association of ultra-processed food consumption with colorectal cancer risk among men and women: results from three prospective US cohort studies","volume":"378","author":"Wang","year":"2022","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.02.006_bib151","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/JCP.0000000000001481","article-title":"A double-blind, placebo-controlled trial of bupropion add-on to olanzapine or risperidone in overweight individuals with schizophrenia","volume":"41","author":"Weizman","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.02.006_bib152","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1099800414562025","article-title":"Factors associated with hyperphagic behavior in patients with dementia living at home","volume":"17","author":"Wen Chi","year":"2015","journal-title":"Biol. Res. Nurs."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.02.006_bib153","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.02.006_bib154","first-page":"10","article-title":"Anorexia: a literature review of young people's experiences of hospital treatment","volume":"33","author":"Williams","year":"2021","journal-title":"Nurs. Child. Young People"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNF.0000000000000263","article-title":"Prescribing trends of atypical antipsychotic drugs in an outpatient unit of a child and adolescent clinic in Turkey","volume":"41","author":"Yekta\u015f","year":"2018","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.02.006_bib156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/bjpo.bp.115.002576","article-title":"Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials","volume":"2","author":"Zhao","year":"2016","journal-title":"BJPsych Open"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:34:41Z","timestamp":1758368081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395623000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":156,"alternative-id":["S0022395623000663"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.02.006","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}